Thereby, the optimal k value that allows splitting Mb and Nb also defined three tumour groups within Smarcb1-deficient tumours: CD8(+)T-cell lymphomas and two other subgroups (Fig. 5a). This evidence concerns the gene SMARCB1 and T-cell non-Hodgkin lymphoma.